Streptococcus suis, Pasteurella multocida inactivated vaccine and preparation method thereof
A technology of Pasteurella and Streptococcus suis, which is applied in the direction of antibacterial drugs, pharmaceutical formulas, bacterial antigen components, etc., can solve problems such as waste, ineffective drug treatment, and antibiotic drug residues, and achieve the effect of easy operation and cost reduction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0031] This product is selected from the pathogenic strain C55138 strain of Streptococcus equi subspecies zooepidemicus strain C55138, the streptococcus strain C55914 strain D group, the virulent strain C55949 streptococcus strain E group E and the Streptococcus suis type 2 HA9801 strain. Streptococcus capsular group A and capsular group B bacteria are inoculated in a suitable medium for culture, the culture is inactivated by formaldehyde solution, residual toxins are removed, and aluminum hydroxide gel is added to concentrate and prepare it. It is used to prevent streptococcus lamblia Various bacterial infections caused by group C, Streptococcus suis type 2, Pasteurella capsule group A and capsule B group bacteria. This includes several of the most important bacterial diseases that are currently prevalent. The strains used in the manufacture and inspection of this product are Streptococcus equi subspecies zooepidemic strain C55138, Group D streptococcus strain C55914, Strepto...
Embodiment 2
[0067] Example 2 Efficacy Research
[0068] With 30 healthy susceptible pigs, 2ml of the vaccine prepared in Example 1 was injected intramuscularly, containing 1 dose; 21 days later, each virulent strain was used for virulent challenge.
[0069] Streptococcus group C strain C55138
[0070] Select 5 immunized pigs, together with 3 control pigs with the same conditions, inject the lethal dose of virulent bacteria liquid of C55138 strain, and observe for 10 days. If more than 4 / 5 of the immunized pigs are protected and more than 4 / 5 of the control pigs die, they are qualified.
[0071] Streptococcus suis type 2 HA9801 strain
[0072] Select 5 immunized pigs, together with 5 control pigs with the same conditions, to attack with a lethal dose of HA9801 virulent strain, and observe for 10 days. More than 4 / 5 of the control group died, and more than 4 / 5 of the immunized group were protected, which was judged as qualified.
[0073] Group D strain C55914
[0074] Take 5 immunized pi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com